Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Molecular Genetics and Metabolism|December 24, 2014
Targeting novel signaling pathways for resistant acute myeloid leukemiaKathleen M Sakamoto, Steven Grant, Diana Saleiro, et al.
The Journal of Clinical Investigation|February 5, 2008
Constitutive activation of SHP2 in mice cooperates with ICSBP deficiency to accelerate progression to acute myeloid leukemiaIwona Konieczna, Elizabeth Horvath, Hao Wang, et al.
The Journal of Biological Chemistry|May 29, 2023
Nore1 inhibits age-associated myeloid lineage skewing and clonal hematopoiesis but facilitates termination of emergency (stress) granulopoiesisOlatundun Williams, Liping Hu, Weiqi Huang, et al.
Cancer Biology & Therapy|February 6, 2014
Resveratrol enhances the suppressive effects of arsenic trioxide on primitive leukemic progenitorsEdward J Wu, Dennis J Goussetis, Elspeth Beauchamp, et al.
Blood Advances|November 23, 2022
Dynamin-2 deficiency causes age- and sex-dependent neutropenia and myelodysplasia in miceAlexander J Willis, Seth J Corey, Carlos Murga-Zamalloa, et al.
The Journal of Biological Chemistry|July 14, 2009
Role of Schlafen 2 (SLFN2) in the generation of interferon alpha-induced growth inhibitory responsesEfstratios Katsoulidis, Nathalie Carayol, Jennifer Woodard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 5, 2008
Dual regulatory roles of phosphatidylinositol 3-kinase in IFN signalingSurinder Kaur, Antonella Sassano, Ajith M Joseph, et al.
The Journal of Biological Chemistry|July 18, 2025
The ubiquitin ligase Triad1 influences myeloid leukemogenesis by regulating the integrated stress responseHao Wang, Francis Suh, Mariafausta Fischietti, et al.
Blood|March 26, 2005
Differential regulation of the p70 S6 kinase pathway by interferon alpha (IFNalpha) and imatinib mesylate (STI571) in chronic myelogenous leukemia cellsSimrit Parmar, Jessica Smith, Antonella Sassano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2014
Autophagy is a survival mechanism of acute myelogenous leukemia precursors during dual mTORC2/mTORC1 targetingJessica K Altman, Amy Szilard, Dennis J Goussetis, et al.
Pageof 8